Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M

Lexicon Pharmaceuticals reports 2018 executive compensation

Published: March 14, 2019

Lexicon Pharmaceuticals reported fiscal year 2018 executive compensation information on March 14, 2019.

In 2018, five executives at Lexicon Pharmaceuticals received on average a compensation package of $1.7M, a 23% increase compared to previous year.

Average pay of disclosed executives at Lexicon Pharmaceuticals

Lonnel Coats, Chief Executive Officer, received $3.1M in total, which increased by 41% compared to 2017. 44.32% of Coats' compensation, or $1.4M, was in option awards. Coats also received $402.4K in bonus, $634.2K in salary, $690.6K in stock awards, as well as $12K in other compensation.

For fiscal year 2018, the median employee pay was $195,778 at Lexicon Pharmaceuticals. Therefore, the ratio of Lonnel Coats' pay to the median employee pay was 16 to one.

Praveen Tyle, Executive Vice President, Research and Development, received a compensation package of $1.5M, which increased by 13% compared to previous year. 36.98% of the compensation package, or $541.8K, was in option awards.

Jeffrey L. Wade, Chief Financial Officer, earned $1.4M in 2018, a 16% increase compared to previous year.

Pablo Lapuerta, Chief Medical Officer, received $1.3M in 2018, which increases by 17% compared to 2017.

Alexander A. Santini, Executive Vice President and Chief Commercial Officer, earned $1.2M in 2018, a 15% increase compared to previous year.